Keymed Biosciences Inc. - PE Ratio

The PE Ratio as of September 2026 (TTM) for Keymed Biosciences Inc. (2162.HK) is 23.48

According to Keymed Biosciences Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 23.48. This represents a change of -286.36% compared to the average of -12.60 of the last 4 quarters.

Keymed Biosciences Inc. (2162.HK) Historical PE Ratio (quarterly & annually)

How has 2162.HK PE Ratio performed in the past?

The mean historical PE Ratio of Keymed Biosciences Inc. over the last ten years is -32.27. The current 23.48 PE Ratio has changed -7376.41% with respect to the historical average. Over the past ten years (40 quarters), 2162.HK's PE Ratio was at its highest in in the June 2022 quarter at 345.13. The PE Ratio was at its lowest in in the June 2020 quarter at -96.81.

Keymed Biosciences Inc. (2162.HK) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Keymed Biosciences Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Keymed Biosciences Inc. (2162.HK) Average PE Ratio

How has 2162.HK PE Ratio performed in the past?

The current PE Ratio of Keymed Biosciences Inc. (2162.HK) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Keymed Biosciences Inc. (2162.HK) PE Ratio vs. Peers

How is 2162.HK’s PE Ratio compared to its peers?

Keymed Biosciences Inc.’s PE Ratio is greater than Everest Medicines Limited (-150.04), greater than InnoCare Pharma Limited (23.30), greater than Guangzhou Innogen Pharmaceutl Grp Co Ltd (-4.59), greater than Zai Lab Limited (-13.84), less than Lepu Biopharma Co., Ltd. (23.96), greater than Ascentage Pharma Group International (-6.87), less than CanSino Biologics Inc. (327.59), less than Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (68.41), less than HUTCHMED (China) Limited (143.78), greater than Nanjing Leads Biolabs Co Ltd (-36.51),

Build a custom stock screener for Keymed Biosciences Inc. (2162.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Keymed Biosciences Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Keymed Biosciences Inc. (2162.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Keymed Biosciences Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.